Table 7

Summary of the properties of AMA1 epitopes

Epitope

HLA-restriction

Amino acids

Sequence

Location

Crystal

face

Accessibility


E1

B44

13-21

FEFTYMINF

Signal

E2

B44

35-44

SDVYRPINEH

Prodomain

E3

B08

47-55

HPKEYEYPL

Prodomain

E4

B44

51-59

YEYPLHQEH

Prodomain

E5

B08

175-183

YLKDGGFAF

Domain I

F/B

YnaKD

E6

A01

194-202

TLDE+MRHFY

Domain I

B

D, E, H, F

E7

A01

198-207

MRHFYKDNKY

Domain I

F/B

H, F, D, K, Y

E8

B44

327-335

NEFPAIDLF

Domain II

F/B

E, P, I

E9

A02

339-346

KLVFELS*A

Domain II

F

E, L

E10

A01

389-397

RYKSHGKGY

Domain II

F

H, K, Y

E11

A02

405-414

ETQKCEIFNV

Domain II

B

E, T, Q, N

E12

A02

406-414

TQKCEIFNV

Domain II

F

T, Q, N

E13

A02

410-419

EIFNVK*PTCL

Domain II

F

NK

E14

B44

520-528

NEVVVKE*EY

Domain III

F

VEE


Variable amino acids are highlighted in bold.

*Indicated that there is only one variant of <0.001% frequency

E+ is essential for binding of growth inhibitory MAb 1F9

F = front, B = back, F/B = wraps from front to back

Yna Accessibility not available for amino acid Y

Confirmed epitope numbers are indicated in bold

Sedegah et al. Malaria Journal 2010 9:241   doi:10.1186/1475-2875-9-241

Open Data